Popularity #717Earnings are out
Abivax (ADR) (ABVX)
Develops oral obefazimod for ulcerative colitis and Crohn's disease.
$98.54
After hours+0.27 (+0.27%)
At close$98.27(−5.01%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 67.92% | 53.34M ADS | |
|---|---|---|---|
| 367 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 5.00% | 3.92M ADS | |
| 1 holder · as of Feb 13, 2026 | |||
| Strategic holders | 8.22% | 6.46M ADS | |
| 1 holder · as of Nov 14, 2025 | |||
| Other | ≈ 18.86% | 14.82M ADS | |
| remainder | |||
78.54M ADS as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
367 holders · 53.34M shares · 97 new positions · 191 increased · 106 reduced · 42 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| TCG Crossover Management, LLC | 6.01M | 7.65% | −473.3K | Aug 14, 2026 |
| Darwin Global Management, Ltd. | 3.62M | 4.61% | +152.9K | Aug 14, 2026 |
| Helikon Investments Ltd | 2.79M | 3.55% | +1.77M | Aug 11, 2026 |
| Vestal Point Capital, LP | 2.35M | 2.99% | +849.4K | Aug 14, 2026 |
| Jupiter Topco LLC | 1.91M | 2.44% | +1.91Mnew | Aug 14, 2026 |
| UBS Group AG | 1.84M | 2.35% | −2.70M | Aug 13, 2026 |
| Adar1 Capital Management, LLC | 1.80M | 2.30% | +410.7K | Aug 14, 2026 |
| Caligan Partners LP | 1.56M | 1.98% | +96.0K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| TCG Crossover GP I, LLC | 8.30% | 6.46M | 13G | Nov 14, 2025 |
| Invus Public Equities, L.P. | 5.00% | 3.92M | 13G | Feb 13, 2026 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.